Correlations between numerical chromosomal aberrations in the tumor and peripheral blood in canine lymphoma

Cytogenetic and Genome Research

Volumn 124, Issue 1, 2009, Pages 12-18

  Devitt, J J ^a   Maranon, D G ^a   Ehrhart, E J ^a   Bachand, A M ^a   Lana, S E ^a   Larue, S M ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; BONE MARROW BIOPSY; CANCER STAGING; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DOG; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; IMMUNOPHENOTYPING; LYMPHADENECTOMY; LYMPHOMA; MALE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CHROMOSOME ABERRATIONS; CHROMOSOMES, MAMMALIAN; CYTOGENETICS; DOG DISEASES; DOGS; FEMALE; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPH NODES; LYMPHOMA; MALE; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY; TRISOMY; TUMOR CELLS, CULTURED;

CANIS FAMILIARIS;

EID: 65349175991     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000200083     Document Type: Article

References (14)

1. Baskin CR, Couto CG, Wittum TE: Factors influencing first remission and survival in 145 dogs with lymphoma: a retrospective study. J Am Anim Hosp Assoc 36: 404-409 (2000).
2. Carter RF, Valli VE, Lumsden JH: The cytology, histology and prevalence of cell types in canine lymphoma classified according to the National Cancer Institute Working Formulation. Can J Vet Res 50: 154-164 (1986).
3. Hahn KA, Richardson RC, Hahn EA, Chrisman CL: Diagnostic and prognostic importance of chromosomal aberrations identified in 61 dogs with lymphosarcoma. Vet Pathol 31: 528-540 (1994).
4. Khanna C, Lindblad-Toh K, Vail D, London C, Bergman P, et al: The dog as a cancer model. Nat Biotechnol 24: 1065-1066 (2006).
5. Kim GE, Koom WS, Yang WI, Lee SW, Keum KC, et al: Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis. Head Neck 26: 584-593 (2004).
6. LaRue SM, Fox MH, Withrow SJ, Powers BE, Straw RC, et al: Impact of heterogeneity in the predictive value of kinetic parameters in canine osteosarcoma. Cancer Res 54: 3916- 3921 (1994).
7. Lee MY, Tan TD, Feng AC, Liu MC: Clinicopathological analysis of 598 malignant lymphomas in Taiwan: seven-year experience in a single institution. Am J Hematol 81: 568-575 (2006).
8. Pathak S, Wurster-Hill DH: Distribution of constitutive heterochromatin in carnivores. Cytogenet Cell Genet 18: 245-254 (1977).
9. Reimann N, Rogalla P, Kazmierczak B, Bonk U, Nolte I, et al: Evidence that metacentric and submetacentric chromosomes in canine tumors can result from telomeric fusions. Cytogenet Cell Genet 67: 81-85 (1994).
10. Rudiger T, Weisenburger DD, Anderson JR, Armitage JO, Diebold J, et al: Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 13: 140-149 (2002).
11. Thomas R, Smith KC, Ostrander EA, Galibert F, Breen M: Chromosome aberrations in canine multicentric lymphomas detected with comparative genomic hybridisation and a panel of single locus probes. Br J Cancer 89: 1530-1537 (2003).
12. Vail DM, Young KM: Hematopoietic tumors, in Withrow SJ, Vail DM (eds): Withrow and MacEwen's Small Animal Clinical Oncology 4th ed., pp 699-784 (Saunders, Philadelphia 2007).
13. Weller RE, Theilen GH, Madewell BR: Chemotherapeutic responses in dogs with lymphosarcoma and hypercalcemia. J Am Vet Med Assoc 181: 891-893 (1982).
14. WHO: Report of the Second Consultation of the Biological Behavior and Therapy of Tumors of Domestic Animals: Bulletin of the World Health Organization, 1979.